However , zoledronic acid improved IDFS in those who were over @ years since menopause at trial entry ( n = @ ; HR @ , @ % CI @-@ ) but not in all other ( premenopause , perimenopause , and unknown status ) menopausal groups ( n = @ ; HR @ , @ % CI @-@ ) .